- Home
- ATER vs CTXR Comparison
ATER vs CTXR Comparison
Compare ATER & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- CTXR
- Stock Information
- Founded
- ATER 2014
- CTXR 2007
- Country
- ATER United States
- CTXR United States
- Employees
- ATER N/A
- CTXR N/A
- Industry
- ATER Home Furnishings
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- CTXR Health Care
- Exchange
- ATER Nasdaq
- CTXR Nasdaq
- Market Cap
- ATER 15.5M
- CTXR 14.6M
- IPO Year
- ATER N/A
- CTXR N/A
- Fundamental
- Price
- ATER $2.11
- CTXR $0.94
- Analyst Decision
- ATER
- CTXR Strong Buy
- Analyst Count
- ATER 0
- CTXR 2
- Target Price
- ATER N/A
- CTXR $54.50
- AVG Volume (30 Days)
- ATER 64.3K
- CTXR 142.3K
- Earning Date
- ATER 05-14-2025
- CTXR 05-23-2025
- Dividend Yield
- ATER N/A
- CTXR N/A
- EPS Growth
- ATER N/A
- CTXR N/A
- EPS
- ATER N/A
- CTXR N/A
- Revenue
- ATER $99,045,000.00
- CTXR N/A
- Revenue This Year
- ATER N/A
- CTXR N/A
- Revenue Next Year
- ATER $10.62
- CTXR N/A
- P/E Ratio
- ATER N/A
- CTXR N/A
- Revenue Growth
- ATER N/A
- CTXR N/A
- 52 Week Low
- ATER $1.56
- CTXR $0.68
- 52 Week High
- ATER $3.84
- CTXR $26.25
- Technical
- Relative Strength Index (RSI)
- ATER 57.63
- CTXR 51.36
- Support Level
- ATER $1.86
- CTXR $0.65
- Resistance Level
- ATER $2.19
- CTXR $0.82
- Average True Range (ATR)
- ATER 0.12
- CTXR 0.09
- MACD
- ATER 0.04
- CTXR 0.04
- Stochastic Oscillator
- ATER 76.47
- CTXR 85.69
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.